K3's approach to RBM follows ICH E6(R2) and E8(R1): define what matters to the study's integrity, watch it centrally and continuously, and send people to sites when the signals — not the calendar — say so. The result is earlier detection and materially lower monitoring cost than 100% SDV.
Central monitors, statisticians, and clinical operations work as one team, so a statistical signal becomes a site action in days, not review cycles.
What we deliver
- Risk assessment & QTL framework — critical-to-quality factors, thresholds, escalation paths
- KRI design & central statistical monitoring — continuous, study-specific, documented
- Site risk scoring — transparent models your auditors can follow
- Targeted SDV / SDR plans — monitoring effort matched to risk
- Integrated reporting — findings, actions, and outcomes in one record
How we engage
FSP — a standing clinical operations function with governance, SLAs, and capacity planning. Project-based — this scope, one accountable lead, priced to the outcome. Resourcing — senior specialists embedded in your team, compliance-current from day one.
Works with
Optional acceleration
Run RBM on Command Center and risk signals, site actions, and resolution status live in one system — visible to your team in real time.
Our technology portfolio →Classic delivery is the default on every engagement. Platform acceleration is a choice you make — never a condition of working with K3.
At a glance
- Team: senior-level, 92% retention
- Compliance: current, all 50 states
- Systems: designed & validated for 21 CFR Part 11
- Engagement: FSP · project · resourcing
Put a senior clinical operations team on it.
Send the protocol, the RFP, or just the problem. Named people and a scoped approach in return.
Contact K3